Ratnakar Securities Pvt. Ltd.

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals

BSE430.25-4.85 (-1.11 %)

PREV CLOSE ( ) 435.10

OPEN PRICE ( ) 435.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4923

TODAY'S LOW / HIGH ( )428.10 438.25

52 WK LOW / HIGH ( )232.6 571.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988

Management Info

- Chairman Shivakumar Pattabhiraman - Managing Director

Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website www.apollohospdelhi.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

05May Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that meting of the Board o..

04Feb Indraprastha Medical Corporation infor
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..

14Jan Indraprastha Medical Corp informs abou
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..

06Jan Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that the Company has recei..

27Sep Indraprastha Medical Corporation infor
Pursuant to the provisions of the Code of Conduct for Prevention of Insi..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	410.1	1609.9
Gross Profit	552.7	2163.2
Operating Profit	676.7	2669.2
Net Sales	3337.5	13563.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE) 6941.70 (0.98%)	M.Cap ( in Cr)99811.00
Dr Agarwals Eye Hsp (BSE) 4398.25 (1.06%)	M.Cap ( in Cr)2067.18
Max Healthcare Inst (BSE) 1168.45 (2.73%)	M.Cap ( in Cr)113590.50
Yatharth Hospital (BSE) 540.55 (5.97%)	M.Cap ( in Cr)5208.43
Krsnaa Diagnostics (BSE) 675.35 (3.75%)	M.Cap ( in Cr)2180.69

Shareholding Pattern

	PROMOTERS	51%
	NON-INSTITUTION	42.51%
	MUTUAL FUNDS/UTI	2.62%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Small Cap Fund(G)	0.37
Bandhan BSE Healthc...	0.14
Motilal Oswal BSE H...	0.14

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

INDRAPRASTHA MEDICAL CORPORATION LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES